These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1561395)

  • 61. Expanding the spectrum of inflammatory spinal disease: AS it was, as it is now.
    Isdale A; Keat A; Barkham N; Bennett AN; Gaffney K; Marzo-Ortega H; Sengupta R
    Rheumatology (Oxford); 2013 Dec; 52(12):2103-5. PubMed ID: 23873819
    [No Abstract]   [Full Text] [Related]  

  • 62. 2nd International Congress on Spondyloarthropathies. Gent, Belgium, October 4-7, 2000. Abstracts.
    J Rheumatol Suppl; 2000 Aug; 59():1-62. PubMed ID: 10979490
    [No Abstract]   [Full Text] [Related]  

  • 63. 1st International Congress on Spondyloarthropathies. Gent, Belgium, September 22-28, 1998. Abstracts.
    J Rheumatol Suppl; 1998 Aug; 54():1-54. PubMed ID: 9789537
    [No Abstract]   [Full Text] [Related]  

  • 64. Spondyloarthropathies.
    Curr Opin Rheumatol; 1996 Jul; 8(4):B109-18. PubMed ID: 8864594
    [No Abstract]   [Full Text] [Related]  

  • 65. Analysis of N6-Methyladenosine RNA Methylation Regulators in Diagnosis and Distinct Molecular Subtypes of Ankylosing Spondylitis.
    Zhong C; Liang JH; Chen Z; Zhong LP; Sun GD; Xie WX; Wang DP; Zhuang WD; Guo HH; Jin DX; Li YM
    Dis Markers; 2022; 2022():4942599. PubMed ID: 36157216
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Influence of
    Rocha Loures MA; Macedo LC; Reis DM; Oliveira CF; Meneguetti JL; Martines GF; Neves JSF; de Souza E; Sell AM; Visentainer JEL
    Mediators Inflamm; 2018; 2018():1395823. PubMed ID: 29849482
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Efficacy of golimumab on recurrent uveitis in HLA-B27-positive ankylosing spondylitis.
    Yazgan S; Celik U; Işık M; Yeşil NK; Baki AE; Şahin H; Gencer E; Doğan İ
    Int Ophthalmol; 2017 Feb; 37(1):139-145. PubMed ID: 27154720
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Efficiency of adalimumab, etanercept and infliximab in ankylosing spondylitis in clinical practice.
    Escudero-Vilaplana V; Ramírez-Herráiz E; Alañón-Plaza E; Trovato-López N; García-Vicuña R; Carreño-Pérez L; Morell-Baladrón A; Sanjurjo-Sáez M
    Int J Clin Pharm; 2015 Oct; 37(5):808-14. PubMed ID: 25910480
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effect of HLA-B and HLA-DR genes on susceptibility to and severity of spondyloarthropathies in Mexican patients.
    Vargas-Alarcón G; Londoño JD; Hernández-Pacheco G; Pacheco-Tena C; Castillo E; Cardiel MH; Granados J; Burgos-Vargas R
    Ann Rheum Dis; 2002 Aug; 61(8):714-7. PubMed ID: 12117677
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Heat shock protein 70 gene polymorphisms in Mexican patients with spondyloarthropathies.
    Vargas-Alarcón G; Londoño JD; Hernández-Pacheco G; Gamboa R; Castillo E; Pacheco-Tena C; Cardiel MH; Granados J; Burgos-Vargas R
    Ann Rheum Dis; 2002 Jan; 61(1):48-51. PubMed ID: 11779758
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pathways of cell activation in spondyloarthropathies.
    Fearon U; Veale DJ
    Curr Rheumatol Rep; 2001 Oct; 3(5):435-42. PubMed ID: 11564376
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Frequency of triggering bacteria in patients with reactive arthritis and undifferentiated oligoarthritis and the relative importance of the tests used for diagnosis.
    Fendler C; Laitko S; Sörensen H; Gripenberg-Lerche C; Groh A; Uksila J; Granfors K; Braun J; Sieper J
    Ann Rheum Dis; 2001 Apr; 60(4):337-43. PubMed ID: 11247862
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Differential Th1/Th2 cytokine patterns in chronic arthritis: interferon gamma is highly expressed in synovium of rheumatoid arthritis compared with seronegative spondyloarthropathies.
    Cañete JD; Martínez SE; Farrés J; Sanmartí R; Blay M; Gómez A; Salvador G; Muñoz-Gómez J
    Ann Rheum Dis; 2000 Apr; 59(4):263-8. PubMed ID: 10733472
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Bactericidal permeability increasing protein (BPI-ANCA marked chronic inflammatory bowel diseases and hepatobiliary diseases].
    Schnabel A; Csernok E; Schultz H; Stoffel M; Herzberg C; Carroll SF; Gross WL
    Med Klin (Munich); 1997 Jul; 92(7):389-93. PubMed ID: 9324622
    [TBL] [Abstract][Full Text] [Related]  

  • 75. HLA-B27 heavy chains contribute to spontaneous inflammatory disease in B27/human beta2-microglobulin (beta2m) double transgenic mice with disrupted mouse beta2m.
    Khare SD; Hansen J; Luthra HS; David CS
    J Clin Invest; 1996 Dec; 98(12):2746-55. PubMed ID: 8981920
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Commented glossary for rheumatic spinal diseases.
    Braun J; Sieper J
    Ann Rheum Dis; 1996 Jan; 55(1):76; author reply 77-8. PubMed ID: 8572742
    [No Abstract]   [Full Text] [Related]  

  • 77. Genetic background and environment contribute synergistically to the onset of autoimmune diseases.
    Luppi P; Rossiello MR; Faas S; Trucco M
    J Mol Med (Berl); 1995 Aug; 73(8):381-93. PubMed ID: 8528740
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Allele-specific B pocket transplant in class I major histocompatibility complex protein changes requirement for anchor residue at P2 of peptide.
    Colbert RA; Rowland-Jones SL; McMichael AJ; Frelinger JA
    Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6879-83. PubMed ID: 7688130
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Spontaneous inflammatory arthritis in HLA-B27 transgenic mice lacking beta 2-microglobulin: a model of human spondyloarthropathies.
    Khare SD; Luthra HS; David CS
    J Exp Med; 1995 Oct; 182(4):1153-8. PubMed ID: 7561688
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The pathogenetic aspects of spondyloarthropathies from the point of view of HLA-B27.
    Kellner H; Yu D
    Rheumatol Int; 1992; 12(4):121-7. PubMed ID: 1439478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.